Prior to Noven, Mr Amanatides served DSM Pharmaceuticals in several senior quality roles. Most recently, Mr Amanatides has served as senior director of quality operations and regulatory affairs, the senior-most quality officer at DSM Pharmaceuticals.
Mr Amanatides holds a master of science degree in biotechnology and molecular biology from Hood College and a bachelor of science degree in biology from Regents College.
Peter Brandt, president and CEO of Noven, said: “Peter will play an important role in our plan to establish Noven as a high growth specialty pharmaceutical company with uncompromised quality systems, controls and procedures. He has substantial experience and a record of accomplishment in the industry, and will lead our continuing efforts to enhance quality operations across the organization.”